26 May 2026

strategyland.uk

Coca-Cola HBC AG (CCH)

Rank #49 of 100 - Consumer Non-Cyclicals - UK Equities

Home/Stocks/Consumer Non-Cyclicals

Coca-Cola HBC AG

CCH.L·Consumer Non-Cyclicals·Market Cap £15.5b

Rank #49 of 100

Data from Excel Model · 100 Stocks Analysed

£42.50

+10.36% YTD

Target: £46.18(+8.7%)

52W: £32.70 - £48.90

Score Analysis

Coca-Cola HBC AG is ranked #49 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

40/100

Average Score

Liquidity

Good32/100

Valuation

Weak80/100

Profitability

Weak80/100

Solvency

Excellent9/100

Asset Efficiency

Excellent15/100

Mkt Trading

Fair45/100

Technical

Excellent21/100

1. Valuation

Score: 80/100

Is CCH undervalued compared to its peers and fair value metrics?

0/5

valuation criteria met

✗

FY26e P/E Ratio

16.9xRank 68/100

✗

FY27e P/E Ratio

15.2xRank 68/100

✗

Price-to-Book

4.17xRank 66/100

✗

Price-to-Tangible Book

12.13xRank 61/100

✗

EV/EBITDA

9.9xRank 45/100

Key Valuation Metrics

Current P/E

18.9x

Price-to-Earnings

FY26e P/E

16.9x

Forward estimate

FY27e P/E

15.2x

Forward estimate

P/B Ratio

4.17x

Price-to-Book

P/TBV

12.13x

Price-to-Tangible Book

EV/EBITDA

9.9x

Enterprise Value

FY26e EV/EBITDA

9.2x

Forward estimate

FY27e EV/EBITDA

9.2x

Forward estimate

Analyst Consensus Target

Current Price

£42.50

Consensus Target

£46.18

Potential

+8.7%

Target

Bloomberg Median Target: £46.00

2. Profitability

Score: 80/100

How profitable is CCH relative to its peers?

1/6

profitability criteria met

✓

TTM Profit Margin

8.1%Rank 35/100

–

Current ROE

26.7%

–

Current ROA

N/A

✗

FY26e EPS

3.21Rank 76/100

–

TTM EPS

3.01

–

Net Income Growth

N/A

Profit Margin

8.1%

ROE

26.7%

FY27e ROE

24.3%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 9/100

How strong is CCH's balance sheet and financial position?

0/4

solvency criteria met

–

Debt-to-Equity

99.3%

–

Interest Coverage

N/A

✗

Debt/EBITDA

Rank 45Rank 45/100

–

Altman Z-Score

3.02

Key Health Metrics

Quick Ratio

0.99

Below 1.0

Cash Ratio

1.19

Debt/Equity

99%

FCF Margin

2.1%

Altman Z-Score

3.02

Safe Zone

01.812.995+

4. Asset Efficiency

Score: 15/100

How efficiently does CCH deploy its assets and intellectual capital?

0/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

–

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

N/A

Overall Asset Efficiency Rank

Rank within sector peers#15/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.